These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1977043)

  • 1. Decrease of HTLV-I infection in haemodialysis patients after donor screening.
    Yamaguchi K; Nishimura Y; Fukuyoshi Y; Machida J; Ueda S; Kusumoto Y; Shimada H; Asamoah-Adu A; Takatsuki K
    Lancet; 1990 Oct; 336(8722):1070. PubMed ID: 1977043
    [No Abstract]   [Full Text] [Related]  

  • 2. [HTLV-I antibody screening of blood donors].
    Schwarzfischer G; Schätzl H; Bäcker U; Weise W; von der Helm K; Deinhardt F
    Beitr Infusionsther; 1991; 28():29-31. PubMed ID: 1725641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of antibodies to human T cell leukaemia/lymphoma virus in blood donors in north London.
    Brennan M; Runganga J; Barbara JA; Contreras M; Tedder RS; Garson JA; Tuke PW; Mortimer PP; McAlpine L; Tosswill JH
    BMJ; 1993 Nov; 307(6914):1235-9. PubMed ID: 8281054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seroepidemiology of hepatitis C virus infection in Japan and HCV infection in haemodialysis patients.
    Yamaguchi K; Kiyokawa H; Machida J; Obayashi A; Nojiri N; Ueda S; Takatsuki K
    FEMS Microbiol Rev; 1994 Jul; 14(3):253-8. PubMed ID: 7522023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood donor HTLV-1 antibody testing.
    Menitove JE
    Transfusion; 1989 Jan; 29(1):1-2. PubMed ID: 2643208
    [No Abstract]   [Full Text] [Related]  

  • 6. Preliminary survey of anti-HTLV-I in northeastern-Thais.
    Burusrux S; Urwijitaroon Y; Romphruk A; Puapairoj C
    J Med Assoc Thai; 1995 Nov; 78(11):628-30. PubMed ID: 8576676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reevaluation of confirmatory tests for human T-cell leukemia virus Type 1 using a luciferase immunoprecipitation system in blood donors.
    Furuta RA; Ma G; Matsuoka M; Otani S; Matsukura H; Hirayama F
    Transfusion; 2015 Apr; 55(4):880-9. PubMed ID: 25363675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HTLV-1 antibodies in hemodialysis patients.
    Méry JP; Fessi H; Dosquet P; Dazza MC; Simon F; Elias A
    Nephron; 1992; 61(1):124. PubMed ID: 1528335
    [No Abstract]   [Full Text] [Related]  

  • 9. HTLV-I: newest addition to blood donor screening.
    Kaplan JE; Khabbaz RF
    Am Fam Physician; 1989 Aug; 40(2):189-95. PubMed ID: 2667300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Screening of sera from the adult populations of some USSR regions for antibodies to the human T-cell leukemia virus type I (HTLV-I)].
    Seniuta NB; Iakovleva LS; Stepina VN; Buachidze LN; Gurova EP; Kologrivova ZA; Kindiakov VM; Gurtsevich VE
    Vopr Virusol; 1990; 35(4):309-12. PubMed ID: 2256315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HTLV-I and blood donors.
    Bolton WV; Wylie BR; Kenrick KG; Archer GT; Hyland CA; Parker SL; Young IF; Maloney RK; Armstrong VA; Keller AJ
    Lancet; 1989 Jun; 1(8650):1324-5. PubMed ID: 2566847
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevalence of HTLV-I virus in blood donors and transfusion in Mali: Implications for blood safety.
    Diarra AB; Kouriba B; Guindo A; Maiga AI; Diabaté DT; Douyon I; Diawara SI; Touré BA; Fonkoro S; Murphy EL; Diallo DA
    Transfus Clin Biol; 2014 Jun; 21(3):139-42. PubMed ID: 24948205
    [No Abstract]   [Full Text] [Related]  

  • 13. [Detection of HTLV-I viral antibodies in donor blood samples].
    Iakovleva LS; Seniuta NB; Stepina VN; Gurtsevich VE; Buachidze LN
    Vopr Virusol; 1989; 34(2):174-6. PubMed ID: 2669334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decline in the positive rate of human T-lymphotropic virus type-1 (HTLV-1) antibodies among blood donors in Nagasaki.
    Chiyoda S; Kinoshita K; Egawa S; Inoue J; Watanabe K; Ifuku M
    Intern Med; 2001 Jan; 40(1):14-7. PubMed ID: 11201362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [HTLV-I/II seroprevalence and risk factors associated with infection in a blood donor population in Córdoba, Argentina].
    Gallego S; Maturano E; Recalde A; Gastaldello R; Sileoni S; Bepre H; Medeot S
    Rev Argent Microbiol; 2001; 33(3):182-6. PubMed ID: 11594010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [HTLV-I transmission by blood transfusion].
    Inaba S
    Rinsho Byori; 1991 Mar; Suppl 88():171-5. PubMed ID: 1856966
    [No Abstract]   [Full Text] [Related]  

  • 17. Is seroprevalence of HTLV-I/II among blood donors in Lebanon relevant?
    Tamim H; Musharrafieh U; Ramia S; Almawi WY; Al-Jisr T; Ayoub T; Nabulsi-Majzoub M; Kazma H; Baz EK
    Am J Infect Control; 2004 Jun; 32(4):220-3. PubMed ID: 15175617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of anti-HTLV-1 in physical-checkup individuals and blood donors in Taiwan.
    Yung CH; Chow MP; Hu HY; Tzeng JL; Wu YS; Lyou JY; Liu WT
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Nov; 25(4):244-51. PubMed ID: 1342641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Declining trends in HTLV-I prevalence among blood donors in Japan.
    Yamaguchi K
    Intern Med; 2001 Jan; 40(1):1-2. PubMed ID: 11201361
    [No Abstract]   [Full Text] [Related]  

  • 20. HTLV-I infections in French Guiana as monitored by western-blot, dot-blot and PCR techniques.
    Moynet D; Berteau F; Astier-Gin T; Legrand E; Sainte-Foie S; Joly F; Moreau JP; Guillemain B
    Leukemia; 1992; 6 Suppl 3():106S-109S. PubMed ID: 1602804
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.